Other ingredients
Gelatin; Rice Flour; Magnesium Stearate (Mg Stearate); Silicon Dioxide (SiO2); FD&C Blue #1; Titanium Dioxide (TiO2)
Image: NIH Office of Dietary Supplements, Dietary Supplement Label Database — No separate image reuse license stated
Merica Labz
Hollow Point
Capsule
Serving size2 Capsule(s)
Servings per containerNot listed
Package50 Capsule(s)
Data retrievedJul 28, 2026
Supplement Facts
Serving size 2 Capsule(s)
Ajuga turkestanica1000 mgDV not established
Epicatechin300 mgDV not established
BioPerine10 mgDV not established
Label directions
Directions: Take 2 capsules daily with food.
Label warnings
Warning: Consuming this product can expose you to chemicals including lead which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov. Warning: This product is only intended for use in healthy adults 18 years of age or older. Keep out of reach of children. Pregnant or nursing women should not use this product. Consult your healthcare provider before using this product especially if you are taking any prescription over the counter medication dietary supplement product or if you have any pre-existing medical condition but not limited to: high or low blood pressure cardiac arrhythmia stroke heart liver kidney or thyroid disease seizure disorder psychiatric disease diabetes difficulty urinating due to prostate enlargement or if you are taking a MAOI (Monoamine Oxidase Inhibitor) or any other medication. Discontinue use and consult your health care professional if you experience adverse reaction to this product. Discontinue use 2 weeks prior to surgery. Do not exceed recommended serving. Do not use if safety seal is broken or missing.
Identity and label version
NIH label record327221
Entered into NIH DSLDMar 25, 2025
UPC / GTIN00658580070816
Manufacturer / distributor on label'Merica Labz LLC
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.
NIH label history (2)
Current labelNIH record 327221Entered Mar 25, 2025
Ajuga turkestanica1000 mg
Epicatechin300 mg
BioPerine10 mg
Label warning: Warning: Consuming this product can expose you to chemicals including lead which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov. Warning: This product is only intended for use in healthy adults 18 years of age or older. Keep out of reach of children. Pregnant or nursing women should not use this product. Consult your healthcare provider before using this product especially if you are taking any prescription over the counter medication dietary supplement product or if you have any pre-existing medical condition but not limited to: high or low blood pressure cardiac arrhythmia stroke heart liver kidney or thyroid disease seizure disorder psychiatric disease diabetes difficulty urinating due to prostate enlargement or if you are taking a MAOI (Monoamine Oxidase Inhibitor) or any other medication. Discontinue use and consult your health care professional if you experience adverse reaction to this product. Discontinue use 2 weeks prior to surgery. Do not exceed recommended serving. Do not use if safety seal is broken or missing.
Earlier labelNIH record 316260Entered Aug 22, 2024
Ajuga turkestanica1000 mg
Epicatechin300 mg
BioPerine10 mg
Label warning: Warning: Consuming this product can expose you to chemicals including lead which is known to the state of California to cause cancer. For more information go to www.P65Warnings.ca.gov. Warning: This product is only intended for use in healthy adults 18 years of age or older. Keep out of reach of children. Pregnant or nursing women should not use this product. Consult your healthcare provider before using this product especially if you are taking any prescription over the counter medication dietary supplement product or if you have any pre-existing medical condition including but not limited to: high or low blood pressure cardiac arrhythmia stroke heart liver kidney or thyroid disease seizure disorder psychiatric disease diabetes difficulty urinating due to prostate enlargement or if you are taking a MAOI (Monoamine Oxidase Inhibitor) or any other medication. Discontinue use and consult your health care professional if you experience adverse reaction to this product. Discontinue use 2 weeks prior to surgery. Do not exceed recommended serving. Do not use if safety seal is broken or missing.
Sources and traceability
- NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026Open source ↗
More from Merica Labz
Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.